Clinical trials
Current Clinical Trials
ECLIPSE: Lu-177-PSMA-I&T for metastic Castration-Resistant Prostate Cancer
A Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer.
SOLAR: Copper Cu64 PSMA I&T Injection in Patients with Histologically Proven Metastatic Prostate Cancer
A Multi-Center, Open-Label, Randomized Phase 1/2 Study of Copper Cu64 PSMA I&T Injection in Patients with Histologically Proven Metastatic Prostate Cancer.